Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Pfizer
ViiV Healthcare
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01276236
First received: December 20, 2010
Last updated: May 16, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)